![Biotechnology and Biomaterial-Based Therapeutic Strategies for Age-Related Macular Degeneration. Part II: Cell and Tissue Engineering Therapies. - Abstract - Europe PMC Biotechnology and Biomaterial-Based Therapeutic Strategies for Age-Related Macular Degeneration. Part II: Cell and Tissue Engineering Therapies. - Abstract - Europe PMC](https://europepmc.org/articles/PMC7758210/bin/fbioe-08-588014-g002.jpg)
Biotechnology and Biomaterial-Based Therapeutic Strategies for Age-Related Macular Degeneration. Part II: Cell and Tissue Engineering Therapies. - Abstract - Europe PMC
![Frontiers | Biotechnology and Biomaterial-Based Therapeutic Strategies for Age-Related Macular Degeneration. Part II: Cell and Tissue Engineering Therapies | Bioengineering and Biotechnology Frontiers | Biotechnology and Biomaterial-Based Therapeutic Strategies for Age-Related Macular Degeneration. Part II: Cell and Tissue Engineering Therapies | Bioengineering and Biotechnology](https://www.frontiersin.org/files/MyHome%20Article%20Library/588014/588014_Thumb_400.jpg)
Frontiers | Biotechnology and Biomaterial-Based Therapeutic Strategies for Age-Related Macular Degeneration. Part II: Cell and Tissue Engineering Therapies | Bioengineering and Biotechnology
![Frontiers | Biotechnology and Biomaterial-Based Therapeutic Strategies for Age-Related Macular Degeneration. Part II: Cell and Tissue Engineering Therapies | Bioengineering and Biotechnology Frontiers | Biotechnology and Biomaterial-Based Therapeutic Strategies for Age-Related Macular Degeneration. Part II: Cell and Tissue Engineering Therapies | Bioengineering and Biotechnology](https://www.frontiersin.org/files/Articles/588014/fbioe-08-588014-HTML/image_m/fbioe-08-588014-g001.jpg)